PARIS and CAMBRIDGE, MA, April 3, 2019 /PRNewswire/ -- ENTEROME SA, a clinical-stage biopharmaceutical company leveraging its unique knowledge of the key functional and molecular interactions between the gut microbiome and the human body to develop targeted therapeutics, today announces...
from PR Newswire: https://ift.tt/2WKjCds
No comments:
Post a Comment